X 
Board Meetings
Home | Market Info | Company Profile | Board Meetings
Fredun Pharmaceuticals Ltd.
BSE CODE: 539730   |   NSE CODE: NA   |   ISIN CODE : INE194R01017   |   01-Aug-2025 Hrs IST
BSE NSE
Rs. 1006.85
-0.2 ( -0.02% )
 
Prev Close ( Rs.)
1007.05
Open ( Rs.)
1019.80
 
High ( Rs.)
1020.00
Low ( Rs.)
980.00
 
Volume
21935
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
Source DateBoard Meeting DateDetails
14-Jul-2025 30-Jul-2025 Quarterly Results
22-May-2025 30-May-2025 Audited Results & Dividend
22-Jan-2025 04-Feb-2025 Quarterly Results
15-Oct-2024 26-Oct-2024 Quarterly Results
26-Sep-2024 03-Oct-2024 A meeting of the Board of Directors(the "Board") of Fredun Pharmaceuticals Limited (the "Company") is scheduled to be held on Thursday,03rd October, 2024 to inter alia consider issue and allotment of Unsecured Foreign Currency ConvertibleBonds (FCCBs), in accordance with the provisions of the SEBI (Issue of Capital and DisclosureRequirements) Regulations, 2018 and the Companies Act, 2013 and any other regulations and rules asapplicable, as amended subject to such regulatory/ statutory approvals as may be required.
22-Jul-2024 29-Jul-2024 Quarterly Results
24-Apr-2024 07-May-2024 Audited Results & Final Dividend
05-Feb-2024 14-Feb-2024 Quarterly Results
08-Dec-2023 16-Dec-2023 Inter alia consider a proposal for fund raising up to Rs.120 crores by way of further public offer, rights issue, American Depository Receipts/Global Depository Receipts/Foreign Currency Convertible Bonds, qualified institutions placement, debt issue, preferential issue or any other method, in accordance with the provisions of the SEBl (Issue of Capital and Disclosure Requirements) Regulations, 2018 and the Companies Act, 2013 and any other regulations and rules as applicable, as amended subject to such regulatory/ statutory approvals as may be required.
31-Oct-2023 08-Nov-2023 Quarterly Results
Page 1 of 7
PREV || NEXT